MLAB 1227: Coagulation Keri Brophy-Martinez - PowerPoint PPT Presentation

1 / 23
About This Presentation
Title:

MLAB 1227: Coagulation Keri Brophy-Martinez

Description:

... EXTRINSIC PATHWAY Monitored by the Protime (PT) test Monitors oral coagulation therapy such as coumadin, coumarin Detects abnormalities in Factor VII, ... – PowerPoint PPT presentation

Number of Views:157
Avg rating:3.0/5.0
Slides: 24
Provided by: kbro3
Category:

less

Transcript and Presenter's Notes

Title: MLAB 1227: Coagulation Keri Brophy-Martinez


1
MLAB 1227 CoagulationKeri Brophy-Martinez
  • Secondary Hemostasis
  • Part Three

2
Extrinsic Pathway Activation
  • Cell injury releases TF into vasculature
  • TF provides the phospholipid component where the
    coagulation factors interact
  • TF complexes with Ca and VIIa to activate X

3
Extrinsic PathwayCoagulation Factors
  • Factor III Tissue Thromboplastin/Tissue Factor
    (TF)
  • Manufactured in most body tissues especially
    lungs, brain, placenta, RBC membranes. Does not
    circulate unless damage occurs to tissues
  • Purpose
  • Attracts calcium ions to help the formation of
    procoagulant enzyme complexes.
  • Converts prothrombin to thrombin

4
Extrinsic Pathway Coagulation Factors
  • Factor VII Proconvertin (Stabile Factor)
  • Produced in liver
  • Vitamin K dependent
  • Is especially sensitive to Coumadin anticoagulant
    therapy
  • Purpose
  • Activated by tissue thromboplastin(TF)

5
Extrinsic Pathway
  • Monitored by the Protime (PT) test
  • Monitors oral coagulation therapy such as
    coumadin, coumarin
  • Detects abnormalities in Factor VII, exclusively,
    but can also pick up deficiencies in the common
    pathway

6
Common Pathway
  • Activation of either or both pathways results in
    the conversion of factor X to Xa
  • In the common pathway all prothrombin is
    converted to thrombin, which in turn is converted
    to fibrin on the phospholipid surface at the site
    of injury.

7
Common Pathway
  • Thrombin enzyme not normally present in plasma.
    Three functions
  • Converts fibrinogen (I) to fibrin (Ia)
  • Causes potent platelet aggregation
  • Aids in stabilizing fibrin clot by activating
    Factor XIII
  • Activates Protein C to control the extent of
    clotting

8
Common Pathway Coagulation Factors
  • Factor X Stuart Factor (Stuart-Prower)
  • Produced in liver
  • Vitamin K dependent
  • Activated form acts with V, Ca and PF3 to form
    active thromboplastin

9
Common Pathway Coagulation Factors
  • Factor V Proaccelerin (Labile Factor)
  • Produced in liver
  • Deteriorates rapidly in room temperature
  • Purpose
  • Essential in thromboplastin formation
  • Increased in pregnancy inflammation
  • Consumed during coagulation, not found in serum

10
Common Pathway Coagulation Factors
  • Factor II Prothrombin
  • Manufactured in the liver
  • Vitamin K dependent
  • Purpose
  • Upon exposure to V, Xa, PF3 and Ca, it is
    converted to thrombin
  • Stimulates platelet aggregation in presence of
    Ca

11
Common Pathway Formation of Fibrin
  • Thrombin acts upon fibrinogen (Factor I) to form
    fibrin (Ia)
  • Fibrin clot is stabilized by Factor XIII by
    crosslinking the fibrin polymers

12
Common PathwayCoagulation Factors
  • Factor I Fibrinogen
  • MW 341,000
  • Normal value in plasma 200-400 mg/dl
  • Manufactured in the liver
  • Absent in serum
  • Purpose
  • Upon exposure to thrombin, forms fibrin

13
Common Pathway Coagulation Factors
  • Factor XIII Fibrin Stabilizing Factor
  • Produced in liver and platelets
  • Necessary to form a stable clot causes a
    crosslinking of fibrin monomers

14
Misc Coagulation Factors
  • Factor IV Calcium
  • Obtained through diet and bone storage
  • Needed in intrinsic and extrinsic pathways
  • Removed by citrate
  • Purpose
  • Acts as a cofactor in many reactions of the
    coagulation cascade
  • Needed for binding to the phospholipid surface,
    proper platelet function, XIII activation

15
Misc Coagulation Factors
  • There is no Factor VI

16
Misc.
  • All enzymatic reactions require a phospholipid
    surface, either supplied by the membranes of
    activated platelets (PF3) or damaged tissues
    (TF). This phospholipid requirement limits
    coagulation reactions to the site and prevents
    clotting.

17
HELP!!! How Will I Ever Get This Down.
  • 1. Simplified enzymatic coagulation event
  • VIII V
  • XII ----XI---IX------X---------II-------IIa-------
    -I
  • VII

18
Next steps
  • Change the sequence to Arabic numerals
  • 8 5
  • 12119102T 1
  • 7
  • T thrombin

19
Learning the PT/PTT Pathways
  • 8 5
  • 12119102T 1
  • 7
  • T thrombin

PT
PTT
20
Vitamin K Dependant Factors
  • C
  • s s
  • 8 5
  • 12119102T 1
  • 7
  • Think of the central core for those requiring
    Vitamin K. Protein C and S also require Vitamin
    K.

Protein C inhibits factors 8 and 5. Indicated by
X
21
Extended Coagulation sequence
  • 8 5
  • 12119102T 1
  • 7

13
22
Misc.
Thrombin sensitive factors Factors destroyed by
plasmin Factors found in platelets
  • 8 5
  • 12119102T 1
  • 7

13
23
References
  • McKenzie, Shirlyn B., and J. Lynne. Williams.
    "Chapter 30." Clinical Laboratory Hematology.
    Boston Pearson, 2010. Print.
Write a Comment
User Comments (0)
About PowerShow.com